<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00432549</url>
  </required_header>
  <id_info>
    <org_study_id>CAPSS-328</org_study_id>
    <nct_id>NCT00432549</nct_id>
  </id_info>
  <brief_title>Detoxification and Treatment of Subjects With Medication Overuse Headache</brief_title>
  <official_title>Evaluation of Almotriptan and Topiramate in the Detoxification and Treatment of Subjects With Medication Overuse Headache</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The New England Center for Headache, P.C.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ortho-McNeil Neurologics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The New England Center for Headache, P.C.</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the benefits of almotriptan used as a transitional
      therapy and topiramate in subjects with medication overuse headaches (MOH.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2007</start_date>
  <completion_date>February 2007</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary measure for the detoxification period</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of days with mild or no pain in the first two weeks of treatment</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary for the prevention of relapse</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain free days through day ninety</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Primary measure for the detoxification period</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days without any headache in the first two weeks of treatment</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary for the prevention of relapse</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache frequency through day ninety</measure>
  </secondary_outcome>
  <enrollment>60</enrollment>
  <condition>Analgesic Rebound Headache</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Almotriptan</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topiramate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Medication overuse headaches 18 years of age and older Must have a diagnosis of
             probable medication overuse headache Must have greater than fifteen headache days per
             month Must be in generally good health Female subjects must be postmenopausal or
             practicing an acceptable method of birth control

        Exclusion Criteria:

          -  Not overusing six or more tablets per day of compounds containing barbituates opioids
             No overuse of triptans Previous failure or side effects with topiramate or almotriptan
             Cannot be pregnant or lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fred D Sheftell, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The New England Center for Headache, P.C.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alfredo DaSilva</last_name>
    <phone>203-322-2748</phone>
    <email>adasilva@nech.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jo-Ann Epstein</last_name>
    <phone>203-322-2748</phone>
    <email>jepstein@nech.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The New England Center for Headache, P.C.</name>
      <address>
        <city>Stamford</city>
        <state>Connecticut</state>
        <zip>06902</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fred D Sheftell, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2007</study_first_submitted>
  <study_first_submitted_qc>February 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2007</study_first_posted>
  <last_update_submitted>February 7, 2007</last_update_submitted>
  <last_update_submitted_qc>February 7, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 8, 2007</last_update_posted>
  <keyword>Medication overuse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Headache Disorders, Secondary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Topiramate</mesh_term>
    <mesh_term>Almotriptan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

